The Impact on Ovarian Reserve of Ovarian Cystectomy Versus Laser Vaporization in the Treatment of Ovarian Endometrioma: a Randomized Clinical Trial
Laser
1 other identifier
interventional
100
2 countries
2
Brief Summary
This is a prospective, multicentric (two centers: 1:San Raffaele Scientific institute, Milan, Italy; 2:Jagiellonian University, Collegium Medicum, Cracow, Poland), randomized (1:1) clinical trial that includes patients undergoing surgery for primary unilateral or bilateral symptomatic endometriomas. The aim of the study is to determine whether and to what extent the two surgical procedures for endometrioma, cystectomy and laser vaporization, affect ovarian reserve. Recently, cystectomy has been questioned as an ideal surgical approach because it may involve excessive removal of ovarian tissue and the loss of follicles; laser vaporization has been proposed as a promising method to preserve ovarian function.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2016
Typical duration for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2016
CompletedFirst Submitted
Initial submission to the registry
July 9, 2017
CompletedFirst Posted
Study publicly available on registry
July 24, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2018
CompletedJuly 24, 2017
July 1, 2017
1.6 years
July 9, 2017
July 20, 2017
Conditions
Outcome Measures
Primary Outcomes (1)
changes in antral follicle count (AFC)
number of follicles with average diameter of 2-10 mm in both ovaries assessed on the second and fifth day of the menstrual cycle
baseline and 3 months
Secondary Outcomes (1)
changes in serum antimullerian hormone (AMH) levels
baseline and 3 months
Study Arms (2)
stripping
ACTIVE COMPARATORstandardized laparoscopic stripping technique
CO2 laser vaporization
EXPERIMENTALdrainage of the cyst content and vaporization of the internal wall with CO2 laser
Interventions
The cyst is stripped from the healthy ovary by traction and countertraction; after the removal of the cyst, hemostasis is achieved by selective bipolar coagulation.
The cyst content is drained and the internal wall is vaporized with CO2 laser beam (AcuPulse Duo, Lumenis, Israel)
Eligibility Criteria
You may qualify if:
- unilateral or bilateral endometriomas
- pain and/or infertility associated with endometriomas
- largest diameter of the endometrioma ≥3 cm and ≤ 8 cm
You may not qualify if:
- intra-operative detection of deep infiltrating endometriosis
- evidence of adenomyosis at the preoperative ultrasound
- previous surgical procedures on the ovaries
- previous unilateral oophorectomy
- previous salpingectomy or hysterectomy
- thyroid disease
- hyperprolactinemia
- diabetes mellitus
- adrenal disorders
- suspected or proven ovarian malignancy
- evidence of premature ovarian failure (POF) or premature menopause
- hormonal treatment within 3 months from baseline ovarian reserve assessment and 3 months after surgery.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
San Raffaele Scientific Institute
Milan, Italy
Jagiellonian University, Collegium Medicum, Cracow, Poland
Krakow, Poland
Related Publications (1)
Candiani M, Ottolina J, Posadzka E, Ferrari S, Castellano LM, Tandoi I, Pagliardini L, Nocun A, Jach R. Assessment of ovarian reserve after cystectomy versus 'one-step' laser vaporization in the treatment of ovarian endometrioma: a small randomized clinical trial. Hum Reprod. 2018 Dec 1;33(12):2205-2211. doi: 10.1093/humrep/dey305.
PMID: 30299482DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Massimo Candiani, MD Prof
San Raffaele Scientific Institute
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
July 9, 2017
First Posted
July 24, 2017
Study Start
January 1, 2016
Primary Completion
August 1, 2017
Study Completion
January 1, 2018
Last Updated
July 24, 2017
Record last verified: 2017-07